Order Article Reprints

Jesus MM, Lage DP, Pimenta BL, Moreira GJL, Pereira IAG, Câmara RSB, Silva AL, Tavares GSV, Falcão KOM, Dias SSG, et al. Immunotherapeutics Combining a Recombinant Chimeric Protein, Monophosphoryl Lipid A, and Miltefosine Against Visceral Leishmaniasis. Pathogens. 2025; 14(12):1202. https://doi.org/10.3390/pathogens14121202

Jesus, Marcelo M., Daniela P. Lage, Breno L. Pimenta, Gabriel J. L. Moreira, Isabela A. G. Pereira, Raquel S. B. Câmara, Ana L. Silva, Grasiele S. V. Tavares, Karolina O. M. Falcão, Saulo S. G. Dias, and et al. 2025. "Immunotherapeutics Combining a Recombinant Chimeric Protein, Monophosphoryl Lipid A, and Miltefosine Against Visceral Leishmaniasis" Pathogens 14, no. 12: 1202. https://doi.org/10.3390/pathogens14121202

Jesus, M. M., Lage, D. P., Pimenta, B. L., Moreira, G. J. L., Pereira, I. A. G., Câmara, R. S. B., Silva, A. L., Tavares, G. S. V., Falcão, K. O. M., Dias, S. S. G., Abrão, D. M., Rodrigues, M. M., Oliveira-da-Silva, J. A., Giusta, M. S., Chávez-Fumagalli, M. A., Roatt, B. M., Galdino, A. S., Christodoulides, M., Freitas, C. S., & Coelho, E. A. F. (2025). Immunotherapeutics Combining a Recombinant Chimeric Protein, Monophosphoryl Lipid A, and Miltefosine Against Visceral Leishmaniasis. Pathogens, 14(12), 1202. https://doi.org/10.3390/pathogens14121202